#USA #New York #Class Action #The Gross Law Firm #Regencell Bioscience

Shareholders Alert: Regencell Bioscience's Class Action Lawsuit

On May 19, 2026, The Gross Law Firm issued an important notice to investors of Regencell Bioscience Holdings Limited, a company traded on NASDAQ under the ticker RGC. The firm has brought to the attention of shareholders that those who purchased shares during a specific class period may be eligible to join a class action lawsuit potentially aimed at recovering losses incurred due to alleged misleading statements made by the company's management.

Background of the Lawsuit

The class action lawsuit centers on actions taken by the company between October 28, 2024, and October 31, 2025. The complaint suggests that during this time, Regencell and its leaders made materially false and misleading claims that pointed to a fabricated image of stability and growth. These statements reportedly failed to disclose significant vulnerabilities and market manipulation risks, which ultimately left investors exposed to substantial financial harm.

The allegations specify that the hidden risks associated with Regencell's stock posed a danger to investors, leading to volatility in the company's shares. Furthermore, it is asserted that these actions attracted increased scrutiny from regulatory bodies, placing Regencell at risk of legal, financial, and reputational damages.

Key Deadlines for Investors

Shareholders interested in participating in this class action are encouraged to act quickly. The last date to register is June 23, 2026. Prospective plaintiffs do not need to be appointed as lead plaintiffs to recover losses; however, it’s essential for those affected to register as soon as possible to secure eligibility.

Investors can initiate their registration through The Gross Law Firm’s website, where they also have access to monitoring services that will provide ongoing updates regarding the case's developments. This resource is invaluable for shareholders who wish to stay informed about the proceedings and any potential outcomes affecting their investments.

Why Choose The Gross Law Firm?

The Gross Law Firm is notable for its dedication to the rights of investors who have suffered from deceitful and fraudulent business practices. Their mission revolves around holding companies accountable for irresponsible conduct that harms stockholders. The firm aims not only to recover losses for clients but also to ensure that companies engage in responsible and ethical business practices.

With a reputation for being extensively knowledgeable about class action laws, The Gross Law Firm appears poised to help investors navigate the complexities of this case successfully. They emphasize that, across all their legal endeavors, prior results do not guarantee future outcomes, yet they continue to advocate for justice on behalf of investors who have been impacted by unethical corporate behavior.

As this case unfolds, it remains crucial for shareholders to remain actively engaged and to take the necessary steps in order to protect their investments. Missing the registration deadline could mean forfeiting the opportunity to recover losses associated with purchasing Regencell shares during the specified class period.

For more information or to register for the class action lawsuit, investors can contact The Gross Law Firm directly through their official website or at their New York office. The firm is dedicated to ensuring that shareholders are informed, supported, and empowered as they navigate the legal paths available to them.

Conclusion

In summary, shareholders of Regencell Bioscience Holdings Limited should not take the ongoing class action lawsuit lightly. Engaging with The Gross Law Firm could offer a viable path toward claiming lost investments while holding the company accountable for its alleged misconduct. The combined efforts of informed shareholders and dedicated legal representation are crucial for seeking justice in this significant case. Don't delay; ensure your eligibility today!